# Context Therapeutics Inc.: Form 8-K, filed Mar 6, 2024

- Company: [Context Therapeutics Inc.](/companies/cntx.md) (CIK 1842952)
- Form: 8-K
- Filed: 2024-03-06
- Accepted by EDGAR: Mar 6, 2024, 07:30 ET
- Period: 2024-02-29
- Accession: 0001842952-24-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842952/000184295224000005/cntx-20240229.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842952/000184295224000005/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842952/000184295224000005/cntx-20240229.htm

Filed Mar 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001842952-24-000005. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.